FUCICORT CREAM

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Active ingredient:

BETAMETHASONE VALERATE EQV BETAMETHASONE; FUSIDIC ACID

Available from:

DKSH SINGAPORE PTE. LTD.

ATC code:

D07CC01

Dosage:

1 mg/g

Pharmaceutical form:

CREAM

Composition:

BETAMETHASONE VALERATE EQV BETAMETHASONE 1 mg/g; FUSIDIC ACID 20 mg/g

Administration route:

TOPICAL

Prescription type:

Prescription Only

Manufactured by:

LEO Pharma A/S

Authorization status:

ACTIVE

Authorization date:

1988-05-03

Patient Information leaflet

145 mm
148 mm
80 mm
Item-num
See detail
000000-00
FUCICORT
®
CREAM
COMPOSITION 
Each gramme contains:
Fusidic acid                                 20 mg
Betamethasone as valerate       1 mg
Preserved with chlorocresol
PROPERTIES
Fucicort
®
cream combines the potent topical antibacterial action of fusidic acid
with the
anti-inflammatory and antipruritic effects of betamethasone.
Betamethasone valerate is
a topical steroid with rapid effect in inflammatory dermatoses. Even
refractory
conditions can often be treated successfully. When applied topically,
fusidic acid is
effective against Staphylococci, Streptococci, Corynebacteria,
Neisseria and certain
Clostridia and Bacteroides. The antibacterial activity of fusidic acid
is not diminished in
the presence of betamethasone.
INDICATIONS
Fucicort
®
cream is indicated in inflammatory dermatoses where bacterial
infection is
present or likely to occur. Inflammatory dermatoses include atopic
eczema, discoid
eczema, stasis eczema, seborrhoeic dermatitis, contact dermatitis,
lichen simplex
chronicus, psoriasis, discoid lupus erythematosus.
DOSAGE
Uncovered lesions:         2–3 daily applications.
Covered lesions:              Less frequent application may be
adequate.
CONTRA-INDICATIONS
Topical corticosteroides are contra-indicated in viral, tuberculous
and fungal skin
infections, perioral dermatitis, acne rosacea and ulcerative
condition.
Hypersensitivity to any component.
PRECAUTIONS
Long-term continuous therapy should be avoided, particularly in the
face, on flexures,
and intertrigenous areas, and in infants and children. Topical
steroids should not be
used extensively in pregnancy – fetal abnormalities have been seen
in animals due to
systemic absorption.
027511-XX
296
ARTWORK
Please return to:
LEO Pharma A/S
Internal Market Access
Industriparken 55 – DK-2750 – Ballerup
Scale                       Get-up              
                           Item No.            
      Rev. No.�

Summary of Product characteristics

FUCICORT® CREAM
COMPOSITION
Each gram contains:
Fusidic acid
20 mg
Betamethasone as valerate
1 mg
Preserved with chlorocresol
PRODUCT DESCRIPTION
White cream
PROPERTIES
Fucicort® combines the potent topical antibacterial action of fusidic
acid with the antiinflammatory and antipruritic
effects of betamethasone. Betamethasone valerate is a topical steroid
with rapid effect in inflammatory dermatoses.
Even refractory conditions can often be treated successfully. When
applied topically, fusidic acid is effective against
Staphylococci, Streptococci, Corynebacteria, Neisseria and certain
Clostridia and Bacteroides. The antibacterial activity
of fusidic acid is not diminished in the presence of betamethasone.
INDICATIONS
Fucicort® is indicated in inflammatory dermatoses where bacterial
infection is present or likely to occur. Inflammatory
dermatoses include atopic eczema, discoid eczema, stasis eczema,
seborrhoeic, dermatitis, contact dermatitis, lichen
simplex chronicus, psoriasis, discoid lupus erythematosus.
DOSAGE
Uncovered lesions: 2–3 daily applications.
Covered lesions:
Less frequent application may be adequate.
CONTRA-INDICATIONS
Hypersensitivity to fusidic acid/sodium fusidate, betamethasone
valerate or to any of the Excipients.
Due to the content of corticosteroid, Fucicort® is contraindicated in
the following conditions: Systemic fungal infections
Primary skin infections caused by fungi, virus or bacteria, either
untreated or uncontrolled by appropriate treatment
(see Special Warnings and Precautions for Use)
Skin manifestations in relation to tuberculosis, either untreated or
uncontrolled by appropriate therapy.
Perioral dermatitis and rosacea
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Long-term continuous topical therapy with Fucicort® should be
avoided.
Depending on the application site, possible systemic absorption of
betamethasone valerate should always be considered
during treatment with Fucicort®.
Due to the content of corticosteroid, Fucicort® should be used with
care near the eyes. Avoid gett